OBJECTIVE: To evaluate the in¯uence of obesity, per se or associated with hypertension, on left ventricular (LV) diastolic function. PATIENTS: Thirty-two obese newly-diagnosed never-treated hypertensives; 32 obese normotensives matched for age, sex and BMI with hypertensives; 32 lean newly diagnosed never-treated hypertensives and 32 lean normotensives, matched for age, sex and 24 h blood pressure (BP) with the obese subjects. METHODS: Twenty-four-hour ambulatory blood pressure monitoring and digitized M-mode LV echocardiograms. PARAMETERS EVALUATED: Twenty-four-hour, day-time and night-time BP and heart rate, percentage nocturnal BP fall; LV end-diastolic diameter index, septal and posterior wall thickness, LV mass index, peak shortening and lengthening rate of LV diameter, peak thinning rate of LV posterior wall. RESULTS: A main effect was found for obesity on LV diameter and LV mass and for hypertension on LV mass; LV systolic function was normal in all the subjects and similar among the four groups; LV diastolic function was signi®cantly reduced in both obese groups with respect to lean ones. This difference persisted after correction of diastolic parameters for 24 h BP and heart rate, LV diameter and LV mass index and disappeared only after correction for body mass index. This latter was inversely related with diastolic parameters only in the obese groups. CONCLUSIONS: Obesity is associated with a preclinical impairment of LV diastolic function in both normotensives and hypertensives; the diastolic impairment is independent of haemodynamic factors, such as 24 h BP and heart rate, and bears no relation to LV geometry in normotensives and only little relation in hypertensives, having therefore to be ascribed to obesity itself.
Introduction
Morbid obesity, even in the absence of systemic hypertension or underlying organic heart diseases, can lead to heart failure, through mechanisms that are not yet completely elucidated. 1 ± 3 Cardiac morphology and function in obese, otherwise healthy, subjects or in obese hypertensives have been evaluated by many authors, looking for some preclinical impairment of systolic andaor diastolic function that could be a potential cause for a subsequent heart failure. The studies have provided con¯icting results: systolic function has been reported to be either normal 4 ± 8 or impaired, 9 ± 13 whereas, as regards diastolic function, this appeared to be more impaired in obese than in lean hypertensives and an impairment of left ventricular (LV) relaxation was also described in obese normotensives. 8 ± 19 The obesity-related diastolic dysfunction has been considered to be independent of cardiac load and geometry, 8, 9, 18 or to evolve from a concomitant myocardial hypertrophy, 14, 17, 19 or from unfavourable LV loading conditions, either alone or in combination. 10, 15 In a recent study, Mureddu and coworkers 5 did not ®nd any signi®cant additive in¯u-ence of obesity on hypertensive diastolic dysfunction.
Part of these discrepancies could be ascribed to differences between the patients' groups as regards age, known duration of hypertension, previous antihypertensive treatment or blood pressure values. These latters, assessed in almost all the studies only by clinic measurements with a sphygmomanometer, were often signi®cantly higher in obese than in lean subjects. Therefore we have considered it of interest to evaluate the in¯uence of obesity, by itself or associated with hypertension, on LV systolic and diastolic function, selecting young adult lean and obese normotensives and newly diagnosed never-treated hypertensives, matched for age, sex, body mass index and 24 h blood pressure (BP).
Materials and methods
From among the patients referred to our out-patients clinics of hypertension and of endocrinology, we All the hypertensive patients were newly diagnosed ( 10 months) and had never been treated with antihypertensive drugs. The normotensive lean controls were recruited from an epidemiological survey of the employees of Postal and Telegraph services.
Other criteria of selection were as follows: good quality echocardiogram (we evaluated 121 subjects, 57 of whom were excluded because the echocardiogram was not suitable for computerized analysis); no clinical, electrocardiographic or echocardiographic signs of coronary heart disease or valvular diseases; no systemic diseases, such as diabetes mellitus or connective tissue disorders, able per se to in¯uence LV morphology and function; no attempts to lose weight by means of diet or drugs during the 6 months before the study.
The study was approved by the Ethical Committee of the Department of Clinical and Biological Sciences and all the subjects gave their informed consent.
Echocardiographic examination
Immediately after the 24 h ambulatory BP monitoring, each subject underwent an echocardiographic examination performed using a Hewlett-Packard Sonos 1500 with a 2.0a2.5 MHz transducer. LV M-mode echocardiograms were recorded under two-dimensional control, at a paper speed of 100 mmas, with a simultaneous ECG. The M-mode tracings were blindly evaluated by a single operator who digitized four consecutive cardiac cycles of each echocardiogram, as originally described by Upton and Gibson, 20 using a Numosonic 2205 graphic tablet. An IBM personal computer processed digitized data, averaging the four cardiac cycles. We evaluated: LV end-diastolic diameter, end-diastolic thickness of interventricular septum and posterior wall, LV mass, 21 peak shortening rate of LV diameter, peak lengthening rate of LV diameter, and peak thinning rate of LV posterior wall. LV mass was normalized for height to the 2.7 power and LV diastolic diameter for the ®rst power of height, because we wanted to take into account the in¯uence of obesity on cardiac anatomy, an in¯uence that is partly overlooked using indexation for body surface area. 22 
h ambulatory BP monitoring
Noninvasive ambulatory BP monitoring was performed with a portable automated Takeda TM 2421 and a simultaneous 24 h heart rate monitoring was obtained. The unit was set to take readings every 15 min throughout the 24 h. The following parameters were evaluated: mean 24 h, day-time (from 7.00 am to 10.00 pm) and night-time (from 10.00 pm to 7.00 am) systolic and diastolic BP and heart rate, and percentage nocturnal fall of systolic and diastolic BP.
Statistical analysis
Results are expressed as mean AE standard deviation. Comparisons of lean and obese subjects as well as of normotensives and hypertensives were made using two-factor analysis of variance (ANOVA), followed by the Scheffe Â's test. The potential in¯uence of blood pressure and heart rate on LV diastolic function was taken into account by forcing 24 h systolic and diastolic BP and heart rate as covariates into the ANOVA model. In a second step, LV end-diastolic diameter, LV mass and body mass index were sequentially added as covariates in order to control statistically signi®cant between-groups differences for the effects of LV geometry and obesity on diastolic parameters. Multiple regression analysis was used in order to assess the variables independently in¯uencing diastolic function, using as independent variables: age, sex, BMI, 24 h, day-time and night-time BP, heart rate and LV mass index; sex was evaluated as a dummy variable using 1 for men and 2 for women.
Pearson's linear correlation was used to evaluate simple correlations between variables. All the variables were normally distributed and the variances were homogeneous across the groups; the null hypothesis was rejected at a two-tailed value of P`0.05.
Results
After the matching, the four groups were similar as regards demographic characteristics and 24 h heartrate; differences in body size and 24 h BP were detected by design, as were superimposable BP values between the normotensive groups and between the hypertensive groups ( Table 1) .
LV end-diastolic diameter was within the normal limits (`57 mm) in all the subjects, but was greater in obese individuals than in lean subjects in either the presence or absence of hypertension (Table 2) . Septal and posterior wall thickness and LV mass index were higher in both groups of obese subjects and in lean hypertensives compared with lean normotensives and the highest values were found in obese hypertensives (Table 2) . Peak shortening rate of LV dimension, index of LV systolic function, was normal (b1.9 s À1 ) in all the subjects and not signi®cantly different among the four groups. As regards diastolic function, peak lengthening rate of LV diameter and peak thinning rate of LV posterior wall were Obesity and left ventricular diastolic function AM Grandi et al signi®cantly different among the groups, being lower in the two obese groups than in the lean groups; at similar BMI, hypertension was associated with a slight and not statistically signi®cant decrease of diastolic indices ( Table 2 ). The analysis of the interaction term did not show any statistical signi®cant interaction between the two independent variables (obesity and hypertension) in their effects on LV morpho-functional characteristics.
From the analysis of covariance, the adjustment of diastolic parameters for 24 h BP and heart rate left unchanged the signi®cant difference between lean and obese groups. Forcing into the model LV end-diastolic diameter and LV mass as covariates only reduced the level of statistical signi®cance (Table 3) . When body mass index was added in the ANCOVA model, the differences among the four groups as regards both peak lengthening rate and peak wall thinning rate lost the statistical signi®cance (Table 3) . From stepwise multiple regression analysis, the main independent predictor for peak lengthening rate was LV mass index in lean hypertensives (multiple r 0.59, P 0.002, b À0.52, P 0.0027), BMI in obese normotensives (multiple r 0.69, P 0.0035, b À0.61, P 0.0004) and in obese hypertensives (multiple Table 1 ;ÀdDadt, peak shortening rate of LV diameter, s À1 ; dDadt, peak lengthening rate of LV diameter, s À1 ; dWadt, peak wall thinning rate, cmas. Obesity and left ventricular diastolic function AM Grandi et al r 0.62, P 0.019, b À0.51, P 0.009); LV mass index entered the equation only in obese hypertensives (b À0.37, P 0.038). We found similar results as regards peak wall thinning rate (data not shown). Evaluating lean and obese subjects separately, a signi®cant inverse correlation between body mass index and indices of diastolic function was found only in the obese subjects (Figure 1 ), whereas the parameters did not correlate in lean individuals (peak lengthening rate r À0.12, ns; peak wall thinning rate r À0.09, ns).
Discussion
This study was designed to evaluate the in¯uence of obesity on LV diastolic function in normotensives and hypertensives. To do this we planned the matching of the four groups of subjects, in order to avoid some of the possible confounding factors. BP was assessed by means of 24 h ambulatory monitoring and we selected only true normotensives (24 h BP`130a80 mmHg) and sustained hypertensives (24 h BPb140 andaor 90 mmHg). The utmost care was taken to match the patients individually for sex, age, BMI, 24 h systolic and diastolic BP. Moreover we selected obese subjects with upper body obesity, the kind of body fat distribution more linked with cardiovascular diseases, 23 and hypertensive patients newly-diagnosed ( 10 months) and never-treated, as antihypertensive treatment can induce changes in LV morphology and function. 24, 25 In agreement with data from the literature, we found that both obesity and, to a lesser extent, hypertension signi®cantly in¯uenced LV geometry, with obesity affecting both LV diastolic diameter and wall thickness, 4 ± 6,8,9,16,17,19 whereas hypertension only in¯uenced wall thickness. Therefore LV mass was greater in obese than in lean subjects and in hypertensives than in normotensives. As previously reported by some, 4 ± 8 but not all the authors, 9 ± 13 in our young adults, obesity, with or without recent hypertension, did not affect LV systolic function: in fact, peak shortening rate of LV diameter was normal in all the subjects and similar among the four groups.
The main result of our study was the relation between obesity and LV diastolic function. This latter has been evaluated by means of peak lengthening rate and peak wall thinning rate, both derived from digitized M-mode echocardiograms. These indices, less used than Doppler derived parameters, have been demonstrated to be more sensitive in discriminating between normal and impaired diastolic function in the presence of myocardial hypertrophy; they are also less in¯uenced by heart rate and events occurring during isovolumic relaxation. 26 Both diastolic indices were signi®cantly lower in obese than in lean groups. Diastolic dysfunction is a key feature of hypertensive cardiomyopathy, 27, 28 but in our young adults obesity appears far more relevant than recently diagnosed hypertension in affecting LV diastolic function: in obese normotensives diastolic indices were signi®cantly lower than in lean hypertensives and, at similar BMI, peak lengthening rate and peak wall thinning rate were only sligthly and not signi®-cantly lower in hypertensives compared with normotensives, despite a signi®cantly greater mass in hypertensives. It is, however, known that myocardial hypertrophy and diastolic impairment are not always linked: diastolic dysfunction has been described in hypertensives in either the presence or the absence of LV hypertrophy, 28 ± 30 moreover a clear dissociation of these phenomena has been demonstrated, for instance, in spontaneously hypertensive rats with use of therapeutic intervention that normalized myocardial ®bro-sis and therefore LV stiffness, without affecting myocardial hypertrophy. 31 From our study, the decreased diastolic function found in obese subjects as compared with lean ones, was independent of haemodynamic factors, such as 24 h BP and heart rate, and was also relatively independent of preload and myocardial hypertrophy. In fact, the adjustment of the diastolic parameters for 24 h systolic and diastolic BP and heart rate did not change the signi®cant differences between obese and lean subjects; the adjustment for LV end-diastolic diameter, index of preload, and for LV mass index only reduced the level of signi®cance, con®rming the in¯uence of LV geometry on diastolic function, but obese groups still had signi®cantly lower diastolic indices in comparison with lean subjects. The difference lost statistical signi®cance only after adjustment for body mass index.
The relative independence of diastolic impairment from LV geometry in obesity was also con®rmed by the results of multiple regression analysis: high body mass index was the major independent determinant of diastolic function in obese normotensives and obese hypertensives, with, only in this latter group, a far less signi®cant in¯uence of LV mass.
These results and the ®nding of a signi®cant inverse correlation between body mass index and LV diastolic Figure 1 Correlation between body mass index (BMI) and peak thinning rate of LV posterior wall (dWadt ) in normotensive and hypertensive obese subjects.
Obesity and left ventricular diastolic function AM Grandi et al parameters only in obese subjects indicate that overweight plays a relevant role in the development of diastolic dysfunction, which appears to be a primary feature of cardiomyopathy associated with obesity. The design and methods of the present study do not allow an assessment of mechanisms involved in the development of diastolic dysfunction in obesity. However it could be hypothesized that, apart from the development of an echocardiographically detectable hypertrophy, structural changes of the myocardium, such as the described myocardial fatty in®ltration, 32 might affect LV relaxation in obesity.
In conclusion, in young adults, obesity does not affect LV systolic function, whereas obesity per se is associated with diastolic dysfunction in both normotensive and newly diagnosed never-treated hypertensive subjects; the diastolic impairment appears to be independent of haemodynamic factors, such as 24 h BP and heart rate, and to bear little relation to LV geometry; moreover never-treated hypertension of recent onset seems far less relevant than obesity in affecting LV diastolic function.
